Skip to main content
logo
Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.200
+0.045 (3.90%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Cardiol Therapeutics Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.08
Revenue Growth
------
Gross Profit
-----0.08
Operating Income
-35.59-34.32-40.28-29.79-41.34-38.66
Net Income
-36.35-33.82-36.68-28.13-30.93-31.64
Earnings Per Share
-0.39-0.39-0.51-0.44-0.49-0.73
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27.6721.4230.5834.9359.4783.9
Total Debt
0.120.130.160.170.070.12
Net Cash (Debt)
27.5621.2930.4234.7659.483.78
Net Cash Growth
19.08%-30.01%-12.47%-41.48%-29.10%504.11%
Net Cash Per Share
0.290.240.430.540.951.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-24.22-23.85-25.06-25.18-27.22-23.54
Capital Expenditures
-0.06-0.02-0.02-0.06-0.07-0.01
Free Cash Flow
-24.28-23.88-25.08-25.24-27.3-23.55
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------49091.90%
Pretax Margin
------40170.45%
Profit Margin
------40170.40%
FCF Margin
------29904.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-252.00252.00252.00252.00-
PS Ratio
-----1831.90